Article Versions Notes

Takagi H, Kaji K, Nishimura N, Ishida K, Ogawa H, Takaya H, Kawaratani H, Moriya K, Namisaki T, Akahane T, et al. The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects. Cells. 2021; 10(3):575. https://doi.org/10.3390/cells10030575

Takagi, Hirotetsu, Kosuke Kaji, Norihisa Nishimura, Koji Ishida, Hiroyuki Ogawa, Hiroaki Takaya, Hideto Kawaratani, Kei Moriya, Tadashi Namisaki, Takemi Akahane, and et al. 2021. "The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects" Cells 10, no. 3: 575. https://doi.org/10.3390/cells10030575

Takagi, H., Kaji, K., Nishimura, N., Ishida, K., Ogawa, H., Takaya, H., Kawaratani, H., Moriya, K., Namisaki, T., Akahane, T., Mitoro, A., & Yoshiji, H. (2021). The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects. Cells, 10(3), 575. https://doi.org/10.3390/cells10030575